EPAC vs RTX

EPAC presents a stark contrast between a healthy balance sheet and a severely overvalued market price. While the Piotroski F-Score of 4/9 indicates stable financial health and the company maintains strong margins and low debt, the stock is trading at a massive premium to its Graham Number ($16.82) and Intrinsic Value ($11.13). This valuation gap is exacerbated by negative earnings growth (-18.4% YoY) and a completely bearish technical trend (0/100). Despite strong ROE, the lack of earnings momentum and the significant distance from defensive fair value suggest limited upside and high downside risk.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.